We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

HOLOGIC Diagnostics

HOLOGIC Diagnostics offers innovative technology for cytology, molecular and perinatal testing that helps deliver ans... read more Featured Products: More products

Download Mobile App




Automated Molecular Tests Detect Bacterial Pathogens Causing Infectious Gastroenteritis

By LabMedica International staff writers
Posted on 08 Oct 2025

Infectious gastroenteritis, a common inflammation of the gastrointestinal tract (GI), remains a major public health concern caused by bacterial, viral, or parasitic infections. More...

The disease can range from mild to life-threatening, leading to nearly 200 million cases annually in the U.S., with up to 3 million requiring ambulatory visits. Traditional diagnostic methods for diarrheal illnesses have relied on culture, biochemical, and microscopy-based testing, which are labor-intensive and less sensitive. Now, new automated molecular tests designed to detect common causes of infectious gastroenteritis can deliver tailored, actionable diagnostic results to support fast and informed patient care

Hologic, Inc. (Marlborough, MA, USA) has developed two new automated molecular diagnostic assays, the Panther Fusion Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays, for use on its Panther Fusion System. These tests detect the most common bacterial pathogens responsible for infectious gastroenteritis, providing faster, high-sensitivity results and enabling laboratories to deliver tailored diagnostic insights.

The Panther Fusion assays use advanced molecular technology to identify key bacterial pathogens, including Salmonella, Campylobacter, Shigella, E. coli (including O157), Vibrio, Yersinia, and Plesiomonas. These assays can be performed together or in customizable mini-panels, allowing clinicians to test only for pathogens relevant to the patient’s symptoms, thus reducing unnecessary testing and improving turnaround times.

Testing is performed on the Panther Fusion System, which is an extension of Hologic’s fully automated Panther platform and integrates molecular diagnostics across multiple disease categories. The system supports simultaneous testing for women’s health, respiratory infections, viral load, and transplant viruses. This consolidated platform helps streamline laboratory workflows, maximize efficiency, and minimize manual intervention while delivering precise, rapid results to clinicians.

The Panther Fusion Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays have received FDA 510(k) clearance and CE marking under the European In Vitro Diagnostic Regulation (IVDR). By enabling laboratories to perform customizable and high-throughput molecular testing, the new assays aim to raise global standards for diagnosing GI infections. They not only enhance clinical decision-making but also support antimicrobial stewardship by preventing unnecessary antibiotic prescriptions.

“At Hologic, we recognize that access to a comprehensive range of accurate and fully automated diagnostic tests is essential for laboratories and their patients,” said Jennifer Schneiders, Ph.D., President, Diagnostic Solutions at Hologic. “FDA clearance and CE marking of our first GI pathogen detection tests reflect our dedication to advancing diagnostic innovation, and equipping laboratories and clinicians globally with the tools they need to provide fast and informed care when time matters most.”


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Collection and Transport System
PurSafe Plus®
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The TriVerity IVD test includes the TriVerity cartridge and the Myrna instrument (Photo courtesy of Inflammatix)

Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients

When a patient enters the emergency department in critical condition, clinicians must rapidly decide whether the patient has an infection, whether it is bacterial or viral, and whether immediate treatment... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.